RESUMO
A healthy, balanced diet is essential for both physical and mental well-being. Such a diet must include an adequate intake of micronutrients, essential fatty acids, amino acids and antioxidants. The monoamine neurotransmitters, serotonin, dopamine and noradrenaline, are derived from dietary amino acids and are involved in the modulation of mood, anxiety, cognition, sleep regulation and appetite. The capacity of nutritional interventions to elevate brain monoamine concentrations and, as a consequence, with the potential for mood enhancement, has not been extensively evaluated. The present study investigated an extract from oregano leaves, with a specified range of active constituents, identified via an unbiased, high-throughput screening programme. The oregano extract was demonstrated to inhibit the reuptake and degradation of the monoamine neurotransmitters in a dose-dependent manner, and microdialysis experiments in rats revealed an elevation of extracellular serotonin levels in the brain. Furthermore, following administration of oregano extract, behavioural responses were observed in mice that parallel the beneficial effects exhibited by monoamine-enhancing compounds when used in human subjects. In conclusion, these data show that an extract prepared from leaves of oregano, a major constituent of the Mediterranean diet, is brain-active, with moderate triple reuptake inhibitory activity, and exhibits positive behavioural effects in animal models. We postulate that such an extract may be effective in enhancing mental well-being in humans.
Assuntos
Ansiolíticos/uso terapêutico , Antidepressivos/uso terapêutico , Monoaminas Biogênicas/fisiologia , Suplementos Nutricionais , Inibidores da Captação de Neurotransmissores/uso terapêutico , Origanum/química , Extratos Vegetais/uso terapêutico , Animais , Ansiolíticos/química , Ansiolíticos/metabolismo , Antidepressivos/química , Antidepressivos/metabolismo , Ansiedade/prevenção & controle , Comportamento Animal , Benzoquinonas/análise , Benzoquinonas/farmacologia , Encéfalo/metabolismo , Cimenos , Depressão/prevenção & controle , Suplementos Nutricionais/análise , Descoberta de Drogas/métodos , Células HEK293 , Humanos , Masculino , Camundongos , Inibidores da Monoaminoxidase/química , Inibidores da Monoaminoxidase/metabolismo , Inibidores da Monoaminoxidase/uso terapêutico , Monoterpenos/análise , Monoterpenos/sangue , Monoterpenos/farmacologia , Inibidores da Captação de Neurotransmissores/química , Inibidores da Captação de Neurotransmissores/metabolismo , Inibidores da Captação de Neurotransmissores/farmacologia , Extratos Vegetais/química , Extratos Vegetais/metabolismo , Folhas de Planta/química , Distribuição Aleatória , Ratos , Proteínas da Membrana Plasmática de Transporte de Serotonina/genética , Proteínas da Membrana Plasmática de Transporte de Serotonina/metabolismoRESUMO
We have tested the cognitive abilities of young (2.5 months) and middle-aged (14 months) wild-type C57Bl/6J mice in the IntelliCage, which enables automated monitoring of spontaneous and learning behaviour in a homecage-like environment. No differences were observed either in circadian activity or in performance in the novelty-induced exploration test, but middle-aged mice exhibited decreased exploratory activity overall. In the place learning test module, when mice were free to explore all corners without any negative reinforcement, young mice tended not to learn the task and performed less effectively than the middle-aged group. However, when an air-puff was administered as negative reinforcement following visits to an incorrect corner, young mice learned the task significantly better than middle-aged mice throughout the test period. Our data show that, in freely moving mice, the motivational cues for learning and retrieval of memory are age-dependent and dramatically influence learning and memory performance. Furthermore, the data reported here represent a step towards optimised cognitive test protocols when comparing young and middle-aged mice.